<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05056181</url>
  </required_header>
  <id_info>
    <org_study_id>872/CE Lazio 1</org_study_id>
    <nct_id>NCT05056181</nct_id>
  </id_info>
  <brief_title>&quot;MenPhys: Intervention Protocol for Physical Wellness in Mental Health&quot;</brief_title>
  <official_title>&quot;MenPhys: Intervention Protocol for Physical Wellness in Mental Health&quot;</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Roma La Sapienza</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Roma La Sapienza</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary aim of this project is to establish the acceptability of the PAI (physical&#xD;
      activity intervention) to service users by evaluating if participants can be recruited into&#xD;
      the study and if they complete the intervention.&#xD;
&#xD;
      Secondary aims are to estimate if, compared with treatment as usual (TAU), the PAI&#xD;
      intervention (1) positively impacts on subjects' psychiatric symptoms (2) succeeds in&#xD;
      improving cardiovascular fitness performance. In addition, will be considered the impact of&#xD;
      the PAI versus TAU on sleep behavior, quality of life, drug consumption, reduces sedentary&#xD;
      behaviour and unscheduled readmissions to the department within 30 days and within 7 days&#xD;
      after their dismission.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 2021</start_date>
  <completion_date type="Anticipated">July 2024</completion_date>
  <primary_completion_date type="Anticipated">September 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of patients that will complete the study (Acceptability)</measure>
    <time_frame>24-26 weeks</time_frame>
    <description>to evaluate if participants can be recruited into the study and if they complete the intervention.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anthropometric measures</measure>
    <time_frame>24-26 weeks</time_frame>
    <description>Body Max Index (BMI), in kg/m^2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anthropometric measures</measure>
    <time_frame>24-26 weeks</time_frame>
    <description>height in centimeters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anthropometric measures</measure>
    <time_frame>24-26 weeks</time_frame>
    <description>abdominal circumference in centimeters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anthropometric measures</measure>
    <time_frame>24-26 weeks</time_frame>
    <description>weight in kilograms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-report sedentary behaviour and physical activity</measure>
    <time_frame>24-26 weeks</time_frame>
    <description>International Physical Activity Questionnaire (IPAQ)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiorespiratory Fitness</measure>
    <time_frame>24-26 weeks</time_frame>
    <description>6MWT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep behavior</measure>
    <time_frame>24-26 weeks</time_frame>
    <description>Pittsburgh sleep quality index (PSQI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life (QoL)</measure>
    <time_frame>24-26 weeks</time_frame>
    <description>The Quality of Life Enjoyment and Satisfaction Questionnaire - Short Form (Q-LES-Q-SF)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Motivation to engage in physical activity</measure>
    <time_frame>24-26 weeks</time_frame>
    <description>Behavioral Regulation in Exercise Questionnaire-2 (BREQ-2)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychiatric symptoms</measure>
    <time_frame>24-26 weeks</time_frame>
    <description>brief psychiatric rating scale (BPRS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychiatric symptoms</measure>
    <time_frame>24-26 weeks</time_frame>
    <description>Hamilton Depression Rating Scale (HAM-D)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood samples</measure>
    <time_frame>24-26 weeks</time_frame>
    <description>HIgh Density Lipoproteins (HDL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood samples</measure>
    <time_frame>24-26 weeks</time_frame>
    <description>blood glucose levels</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood samples</measure>
    <time_frame>24-26 weeks</time_frame>
    <description>insulin levels</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood samples</measure>
    <time_frame>24-26 weeks</time_frame>
    <description>triglycerides</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood samples</measure>
    <time_frame>24-26 weeks</time_frame>
    <description>C-reactive Protein (CRP)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood samples</measure>
    <time_frame>24-26 weeks</time_frame>
    <description>Low Density Lipoproteins (LDP)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Severe Mental Disorder</condition>
  <arm_group>
    <arm_group_label>PAI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants assigned to the PAI arm will receive brief information on the benefits of being more active and will be given information about the best way to training. They will receive conventional medical treatment. They will also participate in 2 weeks of training (12 sessions), plus telematic assistance of a specialized practitioner who will follow them during the post-discharge training sessions for a period of 12 weeks, with 3 workouts per week.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TAU</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants assigned to the TAU arm will receive brief information on the benefits of being more active and will be given information about the best way to training. They will also receive conventional medical treatment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Physical Activity</intervention_name>
    <description>Physical activity</description>
    <arm_group_label>PAI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of any SMI&#xD;
&#xD;
          -  Meeting any one of the following criteria as determined by a care co-ordinator:&#xD;
&#xD;
               1. Overweight&#xD;
&#xD;
               2. At risk for or have type 2 diabetes mellitus&#xD;
&#xD;
               3. In the clinician's view, have a sedentary lifestyle&#xD;
&#xD;
               4. Smoke tobacco&#xD;
&#xD;
          -  Ability to provide informed consent&#xD;
&#xD;
          -  Ability to understand Italian&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  under the age of 18&#xD;
&#xD;
          -  not having a diagnosis of SMI&#xD;
&#xD;
          -  be unable to do exercises&#xD;
&#xD;
          -  be unable to give informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 13, 2021</study_first_submitted>
  <study_first_submitted_qc>September 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 24, 2021</study_first_posted>
  <last_update_submitted>September 18, 2021</last_update_submitted>
  <last_update_submitted_qc>September 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Roma La Sapienza</investigator_affiliation>
    <investigator_full_name>Paolo Flocco</investigator_full_name>
    <investigator_title>adjunct professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mental Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

